Literature DB >> 1710824

Long term experience with the prostatic spiral for urinary retention due to benign prostatic hyperplasia.

G Guazzoni1, F Montorsi, R Colombo, V Di Girolamo, L Da Pozzo, P Rigatti.   

Abstract

Twenty high risk patients with benign prostatic hyperplasia and urinary retention were treated by insertion of an intraprostatic spiral. The device was positioned under fluoroscopic guidance using a technique developed by us. The procedure required only local anaesthesia and successfully relieved the obstruction in all patients. At the six-month follow-up full continence had been achieved in 15 patients (75%). Three patients (15%) complained of mild stress incontinence but this was not severe enough to require removal and repositioning of the spiral. A 92-year-old patient reported severe incontinence despite correct positioning of the spiral. Removal of the spiral was necessary in one of the continent patients who was receiving anti-coagulant drugs because of sudden, severe macrohaematuria with subsequent acute urinary retention. The spiral became displaced and required repositioning in one patient. Median residual urine volume was constantly lower than 50 ml and the median maximal flow rate at six-month follow-up was 13.2 ml/s. Our long term follow-up study shows the effectiveness and safety of the prostatic spiral as an alternative treatment for selected patients with urinary retention caused by benign prostatic hyperplasia.

Entities:  

Mesh:

Year:  1991        PMID: 1710824     DOI: 10.3109/00365599109024523

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  4 in total

1.  Susceptibility of male wild type mouse strains to antipsychotic-induced weight gain.

Authors:  Rizaldy C Zapata; Olivia Osborn
Journal:  Physiol Behav       Date:  2020-03-07

2.  PPARG rs3856806 C>T Polymorphism Increased the Risk of Colorectal Cancer: A Case-Control Study in Eastern Chinese Han Population.

Authors:  Jing Lin; Yu Chen; Wei-Feng Tang; Chao Liu; Sheng Zhang; Zeng-Qing Guo; Gang Chen; Xiong-Wei Zheng
Journal:  Front Oncol       Date:  2019-02-19       Impact factor: 6.244

3.  Association of PPARG rs 1801282 C>G polymorphism with risk of colorectal cancer: from a case-control study to a meta-analysis.

Authors:  Jiakai Jiang; Zhiqiang Xie; JunYing Guo; Yafeng Wang; Chao Liu; Sheng Zhang; Weifeng Tang; Yu Chen
Journal:  Oncotarget       Date:  2017-08-10

4.  Chronic GPER1 Activation Protects Against Oxidative Stress-Induced Cardiomyoblast Death via Preservation of Mitochondrial Integrity and Deactivation of Mammalian Sterile-20-Like Kinase/Yes-Associated Protein Pathway.

Authors:  Abdulhafiz Imam Aliagan; Ngonidzashe B Madungwe; Nathalie Tombo; Yansheng Feng; Jean C Bopassa
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-19       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.